Literature DB >> 31261163

Orbital Myositis: A Comprehensive Review and Reclassification.

Alan A McNab1,2.   

Abstract

PURPOSE: Orbital myositis occurs in typical and atypical forms. This review summarizes and updates the current state of knowledge of all forms of inflammation affecting extraocular muscle, excluding thyroid-associated orbitopathy.
METHODS: A comprehensive literature review of orbital myositis was performed.
RESULTS: Orbital myositis typically occurs in an idiopathic acute form, with painful diplopia due to inflammation in 1 or more extraocular muscles of young adult females, which usually responds to a course of oral corticosteroids. Atypical forms include idiopathic chronic or recurrent orbital myositis, and myositis related to systemic autoimmune, inflammatory, and infective conditions. The commonest associated autoimmune condition is inflammatory bowel disease. Immunoglobulin G4-related ophthalmic disease often affects extraocular muscle. Drug reactions and rarely paraneoplastic disease may also cause extraocular muscle inflammation.
CONCLUSIONS: Orbital myositis occurs in a typical acute steroid responsive form, but atypical forms related to specific autoimmune and inflammatory conditions are increasingly recognized. Orbital myositis has many similarities to uveitis and would benefit from a systematic approach to nomenclature, diagnosis, and treatment.

Entities:  

Mesh:

Year:  2020        PMID: 31261163     DOI: 10.1097/IOP.0000000000001429

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  10 in total

Review 1.  Idiopathic Orbital Myositis Revisited.

Authors:  Ilse Mombaerts; Alan A McNab
Journal:  Curr Rheumatol Rep       Date:  2022-02-09       Impact factor: 4.592

Review 2.  Extraocular muscle enlargement.

Authors:  Khizar Rana; Valerie Juniat; Sandy Patel; Dinesh Selva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-17       Impact factor: 3.535

Review 3.  Orbital myositis in systemic lupus erythematosus: a case-based review.

Authors:  Voulgari V Paraskevi; Venetsanopoulou I Aliki; Pieta Antigone; Tziortzioti Zoi; Zikou K Anastasia; Drosos A Alexandros
Journal:  Rheumatol Int       Date:  2022-04-19       Impact factor: 3.580

4.  Clinical heterogeneity between two subgroups of patients with idiopathic orbital inflammation.

Authors:  Toshinobu Kubota; Akari Iwakoshi
Journal:  BMJ Open Ophthalmol       Date:  2022-06

5.  Immunoglobulin G4-related Disease Accompanied by Peripheral Neuropathy: A Report of Two Cases.

Authors:  Tomoya Kawazoe; Tomoyuki Inoue; Shinsuke Tobisawa; Keizo Sugaya; Toshio Shimizu; Kazuhito Miyamoto; Manaka Goto; Naoto Yokogawa; Sanami Azuma; Shingo Itagaki; Kenji Nishida; Yasuhiro Morita; Masahiro Nagao; Eiji Isozaki
Journal:  Intern Med       Date:  2021-01-15       Impact factor: 1.271

6.  Etiology and Clinical Features of Diplopia in South China: Analysis of 303 Cases.

Authors:  Zhonghao Wang; Binbin Zhu; Licheng Fu; Jianhua Yan
Journal:  Front Neurol       Date:  2022-02-16       Impact factor: 4.003

7.  Evaluation of Orbital Lymphoproliferative and Inflammatory Disorders by Gene Expression Analysis.

Authors:  Karim Al-Ghazzawi; Sven Holger Baum; Roman Pförtner; Svenja Philipp; Nikolaos Bechrakis; Gina Görtz; Anja Eckstein; Fabian D Mairinger; Michael Oeverhaus
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

8.  Bilateral Orbital Inflammation as a Manifestation of Paraneoplastic Syndrome.

Authors:  Miyo Yoshida; Kenji Suda; Akio Oishi; Masahiro Fujimoto; Eri Nakano; Satoshi Kashii; Akihiro Ohsumi; Akitaka Tsujikawa
Journal:  Case Rep Ophthalmol       Date:  2022-07-08

9.  Orbital myositis and scleritis after anti-SARS-CoV-2 mRNA vaccines: A report of three cases.

Authors:  Gustavo Savino; Gloria Gambini; Giovanni Scorcia; Nicolino Comi; Claudia Fossataro
Journal:  Eur J Ophthalmol       Date:  2022-09-04       Impact factor: 1.922

10.  Necrotizing myositis in a rectus muscle arising in the setting of long-standing Langerhans cell histiocystosis and recent dabrafenib treatment.

Authors:  Suzanne W van Landingham; Diane Puccetti; Heather Potter; David Gamm; Eli L Diamond; Mark J Lucarelli
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.